Agios Unveils Latest Pyrukynd Mitapivat Findings: Promising Long-Term Safety and Hemoglobin Improvement in Non-Transfusion Dependent Patients

Agios Pharmaceuticals Presents Updated PYRUKYND® Data Actively Enrolling Phase 3 ENERGIZE and ENERGIZE-T Studies Agios Pharmaceuticals, Inc. is currently conducting Phase 3 ENERGIZE and ENERGIZE-T studies to evaluate the effectiveness of PYRUKYND® in adults with non-transfusion-dependent and transfusion-dependent α- or β-Thalassemia, respectively. This innovative drug has shown promise in improving outcomes for patients with these…

Read More

Unlocking the Potential: Kura Oncology Unveils Promising Clinical Findings at ASH Annual Meeting for Menin Inhibitor Ziftomenib in KOMET-001 Trial

Unlocking the Potential: Kura Oncology Unveils Promising Clinical Findings at ASH Annual Meeting for Menin Inhibitor Ziftomenib in KOMET-001 Trial Description: – 30% CR rate at 600 mg in 20 patients with relapsed/refractory NPM1-mutant AML – Low frequency of differentiation syndrome, including 5% rate (1/20) of ≥ Grade 3 among NPM1-mutant patients treated at 600…

Read More

Attention Silvergate Investors: Important Class Action Lawsuit Update and Upcoming Deadline – Kaplan Fox Kilshiemer LLP Alerts Investors

Welcome to Kaplan Fox & Kilsheimer LLP An Investigation into Silvergate Capital Corp Dec 09, 2022 Kaplan Fox & Kilsheimer LLP, a renowned law firm, is currently conducting an investigation on behalf of investors of Silvergate Capital Corp. The firm is looking into claims regarding Silvergate, listed on the New York Stock Exchange under the…

Read More

Voltagrid’s Latest Move: Piloting the Acquisition of CNG Virtual Pipeline Assets and Securing a New Revolving Credit Facility

VoltaGrid Announces the Acquisition of Pilot’s CNG Virtual Pipeline Assets and Closes… A New Chapter in Portable Power Solutions HOUSTON, Dec. 09, 2022 (GLOBE NEWSWIRE) — VoltaGrid LLC (“VoltaGrid” and “Company”) and Pilot Company (“Pilot”) entered into and closed a definitive agreement for VoltaGrid to acquire substantially all assets of Pilot’s CNG compression, CNG virtual…

Read More

Breaking News: Global Tech Industries Group, Inc. Applies for Listing on Blockchain-Powered Securities Exchange – Upstream!

Welcome to the Future: Global Tech Industries Group, Inc. Listing on Upstream Exciting News in the World of Tech Today, Global Tech Industries Group, Inc. announced that it has completed the application process for listing its shares on Upstream, a cutting-edge trading app for digital securities and NFTs. This move signifies a big step forward…

Read More

Breaking News: Cross Country Infrastructure Services Inc. Sells Pump Integrity Segment to Griffin Dewatering

Cross Country Infrastructure Services Inc. Announces Sale of Pump & Integrity Rental Segment AURORA, Colo., Dec. 09, 2022 (GLOBE NEWSWIRE) — Cross Country Infrastructure Services Inc. (“CCIS”), a leading industrial supplier of construction equipment and consumables to infrastructure projects in North America, officially announced today the sale of its Pump & Integrity Rental segment (“Pump…

Read More

Act Now: Important Deadline for Silvergate Shareholders – Johnson Fistel Urges Submission of SI Losses

Silvergate Class Action Lawsuit Announcement SAN DIEGO, Dec. 09, 2022 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Silvergate Capital Corporation (NYSE: SI) (“Silvergate” or the “Company”). The class action is on behalf of shareholders who purchased Silvergate between November…

Read More

Breaking News: Altitude Acquisition Corp. and Global Medical Device Manufacturer Announce Letter of Intent for Business Combination

Altitude Acquisition Corp. Announces Letter of Intent for a Business Combination with a Leading Global Medical Device Manufacturer ATLANTA, Dec. 09, 2022 (GLOBE NEWSWIRE) — Altitude Acquisition Corp. (“Altitude”) (NASDAQ:ALTU), a publicly traded special purpose acquisition company (SPAC), has made a significant announcement today regarding a potential business combination with a leading global medical device…

Read More